TrialSite has chronicled many favipiravir studies and that numerous countries, including Russia, India and China, have accepted the drug as a COVID-19 treatment at least…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.